Effect of Saffron Extract, Astaxanthin, and Carnosic Acid on the Levels of Matrix Metalloproteinase-9 and on Body Weight Changes in Arthritis Experiments
, , , , , , e
03 mar 2023
INFORMAZIONI SU QUESTO ARTICOLO
Categoria dell'articolo: Original Paper
Pubblicato online: 03 mar 2023
Pagine: 26 - 33
Ricevuto: 15 feb 2022
Accettato: 05 ott 2022
DOI: https://doi.org/10.2478/afpuc-2022-0016
Parole chiave
© 2022 Martin C et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Figure 1

Figure 2

Figure 3

Summary of experimental design of three different experiments (a, b, and c)_
Group 1 a, b, c: healthy controls (HC) | Vehiculum | 0.5 ml daily |
Group 2 a, b, c: adjuvant arthritis (AA) untreated | Vehiculum | 0.5 ml daily |
Group 3 a, b, c: AA + treatment | Methotrexate (M) | 0.3 mg/kg twice a week |
Group 4 a: AA + treatment | Saffron extract (SF1) | 25 mg/kg daily |
Group 5 a: AA + treatment | Saffron extract (SF2) | 50 mg/kg daily |
Group 6 a: AA + treatment | SF1+ M | 25 mg/kg + 0.3 mg/kg |
Group 7 a: AA + treatment | SF2 + M | 50 mg/kg + 0.3 mg/kg |
Group 4 b: AA + treatment | Astaxanthin (AS1) | 1 mg/kg daily |
Group 5 b: AA + treatment | Astaxanthin (AS2) | 5 mg/kg daily |
Group 4 c: AA + treatment | Carnosic acid (C) | 100 mg/kg daily |
Group 5 c: AA + treatment | C + M | 100 mg/kg + 0.3 mg/kg |